Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Efficacy of endoscopic gastroduodenal stenting for unresectable gastric cancer with gastric outlet obstruction]Hirokazu Taniguchi, Shigeyuki Tamura, Atsushi Takeno, et al.
JCO Precision Oncology|March 30, 2026
Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA SubstudyYuqing Duan, Tadayoshi Hashimoto, Taro Shibuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of colonoscopy release of intussusception due to sigmoid colon cancer]Hiroki Taenaka, Yoshinori Kagawa, Hideki Sakisaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Analysis of axillary recurrence after breast reconstruction]Masatsugu Okishiro, Chiyomi Egawa, Tomo Ishida, et al.
Annals of Surgical Oncology|October 7, 2024
Prognostic Impact of Thoracic Duct Resection in Patients Who Underwent Transthoracic Esophagectomy Following Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma: Exploratory Analysis of JCOG1109Satoru Matsuda, Hiroya Takeuchi, Ken Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case report of a splenic abscess due to colon cancer in splenic flexure infiltrating into spleen]Yasuo Oneda, Yoshinori Kagawa, Hideki Sakisaka, et al.
International Journal of Clinical Oncology|February 7, 2025
Japan society of clinical oncology position paper on appropriate clinical use of molecular residual disease (MRD) testingShin Kobayashi, Yoshiaki Nakamura, Tadayoshi Hashimoto, et al.
International Journal of Clinical Oncology|March 6, 2026
Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI)Taro Shibuki, Riu Yamashita, Tadayoshi Hashimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2025
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized TrialsMarco Maria Germani, Beatrice Borelli, Tadayoshi Hashimoto, et al.
Therapeutic Advances in Medical Oncology|September 23, 2025
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancerFei Zhang, Izuma Nakayama, Naoya Sakamoto, et al.
Pageof 8